Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
September 29, 2020
Vor Biopharma and Arbor Biotechnologies to Collaborate on Engineered Hematopoietic Stem-Cell Therapies
September 25, 2020
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations
September 23, 2020
Pear Therapeutics Announces Availability of reSET® and reSET-O® to Wellpath Community Care Center Patients; Wellpath to Bring Prescription Digital Therapeutics For Addiction to New Outpatient Treatment Centers
September 21, 2020
Pear Therapeutics and PreferredOne Announce Broad Based Patient Access and Reimbursement for reSET® and reSET-O® for People with Substance Use Disorder and Opioid Use Disorder
September 21, 2020
Aprea Therapeutics Promotes Gregory S. Wessels to Chief Commercial Officer and Announces Governance Changes
September 14, 2020
Cidara Therapeutics to Present New Clinical and Preclinical Data for Rezafungin and Influenza AVCS at IDWeek 2020
September 14, 2020
Escient Pharmaceuticals Raises $77.5 Million Series B Round and Initiates a Phase I/Ib Clinical Trial of EP547, a MRGPR-Targeted Therapy to Treat Cholestatic and Uremic Pruritus
September 9, 2020
Cleave Therapeutics Announces Preclinical Research Collaboration with Jazz Pharmaceuticals in Acute Myeloid Leukemia (AML)
September 3, 2020
Rallybio Appoints Helen M. Boudreau to Board of Directors
September 3, 2020
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
« Previous Page
1
…
49
50
51
52
53
…
118
Next Page »